Last edition
News about "Chris Chen"
Earendil Labs and WuXi Biologics Partner on Bispecific Antibodies and ADCs
Under the agreement, WuXi Biologics will provide end-to-end development and manufacturing services to Earendil Labs, supporting faster regulatory timelines, reliable CMC execution, and scalable global clinical development.
Chris Chen | 13/03/2026 | By News Bureau
WuXi Biologics, Boostimmune Ink MOU for Exclusive R&D Services
WuXi Biologics, Boostimmune Ink MOU for Exclusive R&D Services<br />
Chris Chen | 24/08/2023 | By Sudeep Soparkar | 789
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy